Deferoxamine
- Level
- Commodity
- Parent
- 51172300
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51172301This classification denotes a metal chelator with the molecular formula C25H48N6O8, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier J06Y7MXW4D, chemically known as 3,9,14,20,25-pentaazatriacontane-2,10,13,21,24-pentone, 30-amino-3,14,25-trihydroxy- but more generally known as deferoxamine, which bears U.S. National Institutes of Health Compound Identifier 2973. European Medicines Agency schedules Deferoxamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06942MIG. World Health Organization schedules deferoxamine in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary. DEFEROXAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.
Same parent
Under 51172300 · 40Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.